Form 10-Q LILLY ELI & CO For: Sep 30

Go back to Form 10-Q LILLY ELI & CO For: Sep 30

Eli Lilly (LLY) PT Lowered to $124 at BMO Capital

November 7, 2018 12:40 PM EST

BMO Capital analyst Alex Arfaei lowered the price target on Eli Lilly (NYSE: LLY) to $124.00 (from $130.00) while maintaining an Outperform rating.

The analyst comments, "Lilly had a mixed, incrementally negative 3Q18, but our thesis is unchanged. Although price pressure in the... More